Strides Pharma Completes Pivot Path Stake Sale, Reclassifies Entity as Associate Company
Strides Pharma Science Limited has completed the transaction involving its partnership with Ascent Capital regarding the unlocking of value in Pivot Path. This acquisition results in a change in the status of the company's subsidiary, which will now be classified as an Associate Company starting July 1, 2026.The transaction involved the sale of Strides Pharma Science Limited's majority stake in Pivot Path to a consortium led by Ascent Capital, with co-investor Vintage Classic. The entire aggregate consideration for the sale was approximately ₹1,000 million.
Upon the completion of the deal, the company has received ₹750 million. The remaining balance consideration of ₹250 million is scheduled for payment on the first anniversary of the closing date, as stipulated by the agreed transaction terms.
Following the successful closure of this partnership, Pivot Path will cease to be a Wholly Owned Subsidiary (WOS) of Strides Pharma Science Limited. Effective July 1, 2026, it will henceforth be classified as an Associate Company.
STAR Stock Price Movement
Strides Pharma Science Limited shares today shed 0.04%, settling at ₹1126 as the post-market trading closed for the day. The stock saw a volume of 96,569 shares traded and had ranged between an intraday low of ₹1113.2 and a high of ₹1138.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.